7. Targeted Therapy (Experimental Lymphoma Treatment)
The advancements made in the field of cancer research have recently allowed scientists to develop new types of drugs designed to target the alterations caused in the cells by cancer. Targeted therapy works differently from chemotherapy and usually has less severe side effects. The different types of targeted therapy include proteasome inhibitors like Bortezomib (Velcade), histone deacetylase (HDAC) inhibitors like Romidepsin (Istodax) or Belinostat (Beleodaq), and kinase inhibitors like Ibrutinib (Imbruvica) or Idelalisib (Zydelig).
A study of cutaneous T-cell lymphoma genomics is likely to lead to targeted therapies soon.
